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ABSTRACT 
Karnsrava is a type of Karnaroga, explained by Acharya Sushruta in the 20th chapter named as 
Karnaroga Vigyaniya of Uttara tantra. Karnsrava comprises of broad spectrum of diseases under 
it. And it is hard to find correct correlation of otomycosis with any of the Karnarogas. In the 
present study otomycosis is one of the reasons of otorrhoea/ Karnsrava which is taken for the 
study. Otomycosis is a fungal infection of the ear canal that often occurs due to Aspergillus niger, 
A.fumigatus or Candida albicans. Management of otomycosis can be challenging because of its 
high recurrence rate and of the limited therapeutic options. Keeping in view all these facts, a 
randomized clinical trial was done in PG department of Shalakya Tantra, Patanjali Ayurvedic 
college & hospital, Haridwar. 60 patients were selected and divided into two groups namely 
group A and group B each consisting of 30 patients. Group A patients were treated with 
Gugguluadi Dravyas Karndhoopan twice daily for 7 days and Rasnadi guggulu vati twice daily after 
meal with lukewarm water for 30 days. And Group B patients were treated with Gugguluadi 
Dravyas Karndhoopan twice daily for 7 days and placebo capsules twice daily after meal with 
water for 30 days. Dhoopan is most effective therapy for Karnsrava- otomycosis and Karndhoopan 
is a simple, cost effective procedure which can be done even at the OPD level. Dhoopan dravyas 
has anti- fungal, anti- microbial, analgesic and anti- inflammatory properties.  
It was observed in the present study that group A showed better results than group B. Gugguluadi 
dravyas karndhoopan and Rasnadi Guggulu vati are safe, cost effective and free from any side 
effects in the management of Karnsrava. 
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INTRODUCTION 
Ayurveda is the historical science of life. It has 
always focused at the advancement and preservation 
of desirable fitness in an individual. It is the 
traditional treatment method of India. Karnsrava is a 
disease mentioned by Acharya Sushruta in the 
chapter named Karnaroga Vigyaniya under twenty 
eight Karnarogas[1]. Due to Shiroabhigata, Jala 
Nimmajjana, Karnapaka, Karna vidradi, vitiated Vata 
dosha and Karna becomes Avrudha by Vata and 
results in Karnsrava.[2] But Karnsrava comprises of 
broad – spectrum diseases under it. Thus among of 
numerous causes, due to immersion of water in ear, 
fungus may additionally develop within the ear 
causing the disease otomycosis. In the present study 
otomycosis is one of the reasons of otorrhoea/ 
Karnsrava which is taken for the study. 
Otomycosis is an inflammatory process of 
external ear canal due to infection with fungi and is 
responsible for>9% of the diagnoses of otitis externa. 
In 80% of cases, the etiologic agent is aspergillus, 
whereas Candida is the next most frequently isolated 
fungus. Other more rare fungal pathogens include 
phycomycetes, rhizopus, actinomyces and 
penicillium. Otomycosis is most frequently present 
with pruritus, aural fullness and otorrhea, and may 
also complain of otalgia and hearing loss.[3] 
Prevalence of Otomycosis 
Otomycosis or fungal otitis externa is one of 
the frequently encountered fungal infections of 
external auditory canal. Its prevalence has been 
quoted to range from 9% to 27.2% among patients 
who show signs and symptoms of otitis externa and 
up to 30% in the patient with discharging ears. It is 
worldwide in distribution with a higher prevalence in 
the hot, humid and dusty areas of tropics and 
subtropics.[4] According to American Academy of 
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Otolaryngology, prevalence of otomycosis is 5.2% all 
over world and 9.00% in India.[5] 
Predisposing factors for otomycosis include 
swimming, habitual instrumentation, dermatitis, 
immune compromised sufferes, unhygienic habits, 
pre-existing ear disease etc.[6] In modern science the 
treatment of otomycosis includes cleansing and 
debriding the EAC. Commonly used specific 
antifungal include clotrimazole, nystatin (otic drops 
or powder) and ketoconazole.[3] Clotrimazole is 
tolerated by most patients but in some cases local 
irritation and burning sensation may occur. Oral 
administration of antifungal drugs such as 
itraconazole, voriconazole, can be given to resistant 
cases. But none of them are free from adverse effects 
like nausea, vomiting, headache, loss of appetite, 
rashes and hair loss etc.[7] Studies concluded that, 
there has been an increase in the prevalence of 
otomycosis in recent years that can be linked to the 
extensive use of antibiotic ear drops, vast use of 
steroids, broad-spectrum antibiotics etc.[6] To prevent 
the deleterious effect of these treatments, there is 
need of time to allocate the best, and safe treatment 
for otomycosis. Besides allopathic treatment natural 
source compounds may be used to formulate new or 
more potent and safe anti-fungal agents. According to 
Acharya Sushruta, Karnsrava is treated by 
Shirovirechana (Nasya), Dhoopan, Poorana, 
Pramarjana, Dhaavana and oral drug therapy etc.[8] 
Considering these points, there is requirement for 
search of secure, effective, easily available treatment 
to treat this ear disease. 
Here in the present study for the treatment 
two groups are taken. In Group A Karndhoopan was 
done with Gugguluadi Dravyas which is mentioned in 
Sushrut Sutrasthana[9] and Rasnadi guggulu for oral 
intake. Rasnadi guggulu has been mentioned by 
Yogaratnakara in Karnaroga Chikitsa Adhyaya.[10] In 
Group B Karndhoopan along with placebo (gelatin) 
capsules were given. 
  Karndhoopan with Gugguluadi dravyas has a 
property of Shothaghana, Vednasthapan, Vrana 
Shodhan, Vrana ropana, Kandughan and Jantughan. 
Due to these properties fungal growth in otomycosis 
and inflammation of external auditory canal is 
prevented by Dhoopan. 
The ingredients of Rasnadi guggulu are 
mostly Ushna virya, katu, and Tikta and Kashaya rasa. 
Due to these properties it alleviates Vata and Kapha 
dosha. It is very effective anti- inflammatory and pain 
relieving formulation. So, this clinical trial has been 
selected. 
AIM AND OBJECTIVES OF THE STUDY 
1. To study Karnsrava (otomycosis) in both 
Ayurveda and its modern aspect to establish the 
correlation between these diseases. 
2. To evaluate the combined efficacy of Gugguluadi 
Dravyas Karndhoopan and Rasnadi guggulu in the 
management of Karnsrava- otomycosis. 
3. To evaluate the efficacy of only Gugguluadi 
Dravyas Karndhoopan in the management of 
Karnsrava. 
4. To evaluate the comparative efficacy of both 
groups in the management of Karnsrava. 
MATERIAL AND METHODS 
Selection of Cases 
Patients with classical features of Karnsrava- 
otomycosis were selected randomly from the O.P.D & 
I.P.D. of Shalakya Tantra Department, Patanjali 
Bhartiya Ayurvigyan Evam Anusandhan Sansthan, 
Haridwar. 
Inclusion Criteria  
1. Patient with the age group of 10-70 years. 
2. Patient having specific signs & symptoms of 
Karnsrava-otomycosis on Ayurvedic and Modern 
parameters has been selected. 
Exclusion Criteria 
1. Age below 10 yrs and above 70 yrs. 
2. Pregnant women.  
3. Patients suffering with systemic disease like 
uncontrolled DM, meningitis, Tuberculosis etc. 
4. Patients suffering with tympanic membrane 
perforation and invasive temporal bone 
infections. 
Diagnostic Criteria 
1. Patients were thoroughly examined both 
subjectively and objectively.  
2. Otoscopic examination. 
3. KOH Test. 
4. Routine investigations were done to exclude the 
other pathologies. 
5. Haematological: Hb%, TLC, DLC, ESR. 
6. Routine urine examination. 
7. Random Blood Sugar. 
Collection of Drugs 
The drugs formulations taken for study are- 
Gugguluadi dhoopan dravyas– The ingredients of 
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Table 1: The Ingredients of Dhoopan Varti Dravyas 
S.No. Drug Name Latin Name Part Used Qty (In Part) 
1. Guggulu Commiphora mukul Niryas 1 
2. Agaru Aquilaria agallocha Kandsaar 1 
3. Sarjarasa Shorea robusta Gaertn Niryas 1 
4. Vacha Acorus calamus Mula 1 
5. Gaur sarshapa Sinapis alba Bijj 1 
6. Saindhava Lavana  Sodii chloridum  - 1 
7. Nimba patra Azadirachta indica Patra,Twak 1 
8. Ghrita  -  - 1 
Table 2: The Ingredients of Rasnadi guggulu vati 
S.No Hindi Name  Latin Name  Part Used Qty(In Part) 
 1. Rasna Pluchea lanceolata Leaves 1 part 
 2. Amrita Tinospora cordifolia Stem 1 part 
 3. Eranda Ricinus communis Root  1 part 
 4. Devadaru Cedrus deodara Resin 1 part 
 5. Shunthi Zingiber officinale Rhizome 1 part 
 6. Guggulu Commiphora mukul Resin 5 part 
All the raw material of Gugguluadi dhoopan 
dravyas were procured from Hans herbals private 
limited, Haridwar and were identified with the help 
of Dravyaguna Department of Patanjali, Bhartiya 
Ayurvigyan Evam Anusandhan Sansthan, Haridwar, 
Uttarakhand. Rasnadi gugguluvati was procured from 
Baidyanath Pharmacy. 
Method of Preparation of Karndhoopan Varti 
Dhoopanvarti was prepared in the Ras- 
Shastra Department of Patanjali Bhartiya Ayurvigyan 
Evam Anusandhan Sansthan, Haridwar, Uttarakhand. 
In Karnaroga, particular method of preparation of 
Karndhoopan varti is not mentioned, hence 
Karndhoopan varti was prepared according to classic 
method which is mentioned in Charaka Samhita.[11] 
(ch.su.5/24). 
Material Required For Varti 
 Drugs- Guggulu, Agaru, Sarjras, Vacha, 
Gaursarshapa, Saindhavalavana, Nimba, Go-Ghrita 
(each in equal amount) 
 Grinder 
 Utensil – Stainless steel 
 Cotton cloth 
 Sieve 






1. All the drugs were taken in equal proportion and 
grinded into fine powder. This powdered drug was 
then sieved to remove the unwanted size particles 
and a paste was made of the powdered drug. 
2. A clean cotton cloth was placed on a flat surface 
and a thick paste of powdered drug was applied 
evenly on it which was allowed to dry for 3-4 hrs. 
3. Reed sticks where placed on the cloth and it was 
rolled into layers just like the shape of 
Yavadhanya. 
4. The thickness in middle portion of Varti was like 
the thickness of thumb with tapered ends. Then it 
was allowed to dry in shade. 
5. After it was completely dried the reed sticks were 
removed from the Varti and were ready to be 
used. 
6. Vartis were stored in sterile and moisture free 
container. 
Research Design 
1. It is a randomized comparative, open labelled, 
clinical study. Patients were assigned in two 
groups consisting of 30 patients each excluding 
the dropouts. 
2. Total duration of study- 18 months. 
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Groups Chikitsa Prayoga Prayogaavadhi Nireekshana 
A  Gugguluadi dravyas 
Karndhoopan. 
 Rasnadi Guggulu vati 
orally. 
 Twice in a day 
about 3-5 min. 
 500mg twice daily 
after meal. 
a) For 7 days. 
b) For 30 days. 
(after 7 days of Dhoopan 
procedure) 
2months 
B  Gugguluadi dravyas 
Karndhoopan. 
 Placebo capsules orally. 
 Twice in a day 
about 3-5 min 
 Cap.1-1 bd 
a) For 7 days. 
b) For 30 days. (after 7 days 
of Dhoopan procedure) 
2 months 
10% Potasium Hydroxide (KOH) Test 
A KOH preparation test is also called potassium 
hydroxide preparation test or fungal smear is a 
simple, non- invasive, quick and accurate procedure.  
Material Required For 10% KOH Test 
 10% KOH solution  
 Glass slides  
 Gauze 
 Cover slips 
 Ear wax curette  
 Alcohol swab 
 Sample collected from ear. 
Preparation of 10% KOH Solution 
1. Approximately 10 grams of potassium hydroxide 
pellets was taken into a screw-cap bottle. 
2. Then 50ml of distilled water was added to the 
pellets and mixed till they got completely 
dissolved in it. 
3. Later more distilled water was added till 100ml 
volume was attained and the bottle was labelled as 
10% KOH solution. 
4. Direct microscopy with 10% potassium hydroxide 
was done on the sample. 
Procedure 
1. The material to be examined was placed on a clean 
glass slide. 
2. A drop of 10% KOH was added to the material and 
mixed. 
3. A cover slip was placed over the preparation 
without any air bubbles. 
4. The KOH preparation was kept at room 
temperature until the material was cleared. 
5. The slide was examined for fungal elements under 
the microscope using 10 X and 40 X (high power 
lens) objectives. 
6. The presence of fungal elements (hyphae 
elements, conidiophores, spores) was looked for. 
Karndhoopan Procedure 
Purvakarma  
1. The ear of patient was examined thoroughly and if 
necessary cleaning and mopping was done. 
 
2. Both eyes were covered with bandages so that 
they are not harmed with the fumes.  
Pradhan Karma 
1. The patient was asked to sit on 1 feet high chair 
in comfortable position in a place devoid of dust, 
direct sunlight and cold. 
2. The patient was asked to concentrate on the 
treatment without having any other thoughts in 
mind. 
3. The patient was asked to avoid talking, laughing, 
sneezing and movements of head and neck. 
4. The Dhooma varti was ignited with the help of 
electric heater and allowed to burn till the it 
produced sufficient Dhooma. 
5. The ignited Varti was kept in cone of hard paper 
so that the Dhooma will come out from the 
aperture made at the tip of cone. The aperture at 
the proximal part of cone was approximately 
0.5cm thus the intensity of Dhooma was 
maintained. 
6. The patient was asked to tilt his/her head 
towards affected ear so that Dhooma can be 
properly directed to the EAC of the affected ear. 
7. The procedure was done for 3-5 minutes. 
8. The same procedure was done twice daily – 
morning and evening. 
Paschat Karma 
1. The ear in which Dhoopan was given is covered 
with cotton to prevent its direct exposure to 
cold.  
2. The patient was made to sit for 10 minutes 
wrapping his head and ear in a place which is 
not direct contact of cold. 
3. Patient was asked to avoid head bath till the 
Karndhoopan was advised. 
Follow-Up 
1st followup- 15 days after the completion of 
treatment. 
2nd followup- 15 days after the 1st visit. 
3rd followup- 1 month after the 2nd visit. 
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Criteria for Assessment  
The efficacy of the therapy was assessed on the basis of improvement in subjective and objective criteria. 
Scoring was done as following. 
 Subjective parameters Grade 
1. Itching (Karnakandu) 0- Nil 
1- Occasional 
2- Often itching throughout the day 
3- Itching throughout the day and night and disturb sleep. 
2. Ear Discharge 
(Karnsrava) 
0- Nil 
1- Occasional  
2- Continuous discharge in ear with short history or first time history 
3- Continuous discharge in ear with long history or history of recurrence 
3. Pain(Karnashula) 0- Nil 
1- Mild 1- 4 
2- Moderate 5-7 
3- Severe 8-10 
4. Ear blockage 0- No feeling of blockage  
1- Occasionally feeling of the ear blockage. 
2- Either day or night time feeling of ear blockage  
3- whole day and night feeling of ear blockage 
Objectives Parameters Grade 
Otoscopic examination – 
1. Presence of fungus in 
EAC 
0- Nil 
1- 50% of acoustic canal is affected 
2- 75% of acoustic canal affected 
3- Total length of acoustic canal and tympanic membrane 
2. KOH/SWAB TEST 0-Negative (Fungus hyphae absent) 
1-Positive (fungus hyphae present) 
Ethical Clearance 
This trial has been cleared by Institutional 
Ethical committee (IEC) of Patanjali Bhartiya 
Ayurvigyan Evam Anusandhan Sansthan, Haridwar, 
Uttarakhand. PAC/IEC/2017-2018/16; dated 20/03/ 
2018, before starting the clinical trial on patients of 
Karnsrava- otomycosis. 
Registration in CTRI  
 The present clinical trial has been registered in 
Clinical Trial Registry- India (CTRI). 
 The registration number is CTRI/2019/03/ 
018114 [Registered on: 15/03/2019]- Trial 
registered prospectively. 
OBSERVATION  
The present study revealed higher incidence 
of disease maximum numbers of patients i.e., 38.33% 
were reported to the age group of 21-30 years. 
56.67% of the patients were male, 98.33% of patients 
were from Hindu community, 26.67% were 
housewives, maximum numbers of patients were 
from rural habitat i.e., 71.67%, maximum numbers of 
patients were educated up to higher secondary i.e. 
38.33%, maximum i.e. 76.67% patients were doing 
moderate type of work, 70.00% were married, 
48.33% patients were from lower middle class, 
maximum patients i.e. 75.00% had sound sleep, 
Majority of patients i.e. 80.00% were purely 
vegetarian, majority of the patients i.e. 51.67% were 
having dietary habit of Samashana, maximum 
numbers of patients i.e. 48.33% were having 
Madhyam koshtha. Maximum numbers of patients i.e. 
85.00% were having Mandagni, maximum numbers 
of the patients i.e. 70.00% were having regular bowel 
habit, maximum numbers of the patients i.e. 56.67% 
were addicted to tea, majority i.e. 81.67% of the 
patients had normal built, maximum numbers of the 
patients i.e. 55.00% were taking Madhura rasa 
dominant diet, maximum numbers of patients i.e., 
38.33% were of Vata- Kapha Prakriti, majority of 
patients 75.00% were having Rajasik Manas Prakriti, 
majority of patients 65.00% were having Madhyam 
vikriti, maximum numbers of patients i.e. 76.67% 
were having Madhyam Sara, maximum numbers of 
patients i.e. 76.67% had Madhyam samhanana, 
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majority of the patients i.e. 68.33% were of 
Madhyama Pramana, maximum numbers of patients 
i.e. 85.00% were of Madhyama Satmya, maximum 
numbers of patients i.e. 75.00% were of Madhyama 
Satva, majority of the patients i.e. 71.67% were of 
Madhyama Abhyavaharana Shakti, majority numbers 
of the patients i.e. 80.00% were of Madhyama Jarana 
Shakti, majority numbers of the patients i.e. 63.33% 
were of Madhyam Vyayama Shakti, maximum 
numbers of patients i.e. 78.33% had unilateral 
otomycosis, maximum numbers of patients i.e. 
56.67% were having Nidana of Jalanimajjana/ 
jalakrida, majority of patients i.e. 41.67% were 
having Chronicity of <1 week, month wise prevalence 
of the Karnsrava were found in maximum i.e. 25.00% 
of the patients in September. 100% patients had chief 
complaints of ear pain and itching were reported, 
majority of the patients i.e. 41.67% had manifestation 
of the disease in left ear, whitish types of fungal mass 
was found in maximum numbers of patients i.e. 
51.67%. 
RESULTS 
Table 3: Effect of therapy on subjective criteria in Group A 
Group A 
Median Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
BT AT 
Karnsrava 1 0 -4.491a 0.000 62.34 Significant 
Karnashula 2 0 -4.146a 0.000 63.53 Significant 
Karnakandu 2 0 -4.379a 0.000 65.1 Significant 
Karnapratinaha 2 0 -4.359a 0.000 63.5 Significant 
Since observations are on ordinal scale (gradations), we have used Wilcoxon Signed Rank Test to test 
efficacy. From above table we can observe that P-Values for all parameters are less than 0.05. Hence we 
conclude that effect observed in Group A is significant. 
Also from above table, it can be observed that, median value for Karnsrava was 1 before treatment and 
it is reduced to 0 after treatment showing significant effect of about 62.34% in the symptoms. Median value for 
Karnashula was 2 before treatment, it is reduced to 0 after treatment showing significant effect of about 
63.53% in the symptoms. Median value for Karnakandu was 2 before treatment, it is reduced to 0 after 
treatment showing significant effect of about 65.1% in the symptoms. Median value for Karnapratinaha was 2 
before treatment, it is reduced to 0 after treatment showing significant effect of about 63.5% in the symptoms. 
 
Table 4: Effect of therapy on objective criteria in Group A 
Group A 
Median Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
BT AT 
Fungus 2 0 -4.066a 0.000 60.12 Significant 






Karnasrava Karnashula Karnakandu Karnapratinaha
1
2 2 2
0 0 0 0
Group A Subjective
Median Median
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Median value for Fungus was 2 before treatment, it is reduced to 0 after treatment showing significant 
effect of about 60.12% in the symptom. Median value for KOH’s Test was 1 before treatment, it is reduced to 0 
after treatment showing significant effect of about 62.43% in the symptom. 
 
Table 5: Effect of therapy on subjective criteria in Group B 
Group B  
Median Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
BT AT 
Karnsrava 1 0 -4.456a 0.000 44.36 Significant 
Karnashula 2 1 -4.234a 0.000 45.32 Significant 
Karnakandu 2 1 -4.379a 0.000 42.4 Significant 
Karnapratinaha 1 0 -3.207a 0.000 43.5 Significant 
Since observations are on ordinal scale (gradations), we have used Wilcoxon Signed Rank Test to test 
efficacy. From above table we can observe that P-Values for all parameters are less than 0.05. Hence we 
conclude that effect observed in Group B is significant. 
Also from above table, it can be observed that median value for Karnsrava was 1 before treatment, it is 
reduced to 0 after treatment showing significant effect of about 44.36% in the symptom. 
Median value for Karnashula was 2 before treatment, it is reduced to 1 after treatment showing 
significant effect of about 45.32% in the symptom. Median value for Karnakandu was 2 before treatment, it is 
reduced to 1 after treatment showing significant effect of about 42.4% in the symptom. Median value for 
Fungus was 2 before treatment, it is reduced to 1 after treatment showing significant effect of about 41.5% in 
the symptom. Median value for Karnapratinaha was 1 before treatment, it is reduced to 0 after treatment 
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Table 6: Effect of therapy on objective criteria in Group B 
Group B 
Median Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
BT AT 
Fungus 2 1 -4.600a 0.000 45.13 Significant 
KOH Test 1 0 -3.606a 0.000 42.26 Significant 
Median value for Fungus was 2 before treatment, it is reduced to 1 after treatment showing significant effect of 
about 45.13% in the symptom. 
Median value for KOH’s Test was 1 before treatment, it is reduced to 0 after treatment showing significant 
effect of about 42.26% in the symptom. 
 
Table 7: Comparative effect of therapy between Group A and Group B 









Group A 30 28.75 862.50 
139.000 0.039 Group B 30 23.55 706.50 
Total 60     
Karnashula 
Group A 30 28.55 856.50 
143.000 0.041 Group B 30 23.35 700.50 
Total 60     
Karnakandu 
Group A 30 28.20 846.00 
150.000 0.046 Group B 30 23.00 690.00 
Total 60     
Karnapratinaha 
Group A 30 31.85 955.50 
77.000 0.000 Group B 30 26.65 799.50 
Total 60     
Fungus 
Group A 30 27.35 820.50 
167.000 0.043 Group B 30 22.15 664.50 
Total 60     
KOH Test 
Group A 30 28.73 861.75 
139.500 0.030 Group B 30 23.53 705.75 
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For comparison between Group A and Group B, we have used Mann Whitney U Test. From above table 
we can observe that P-Values for all parameters are less than 0.05. Hence we conclude that there is significant 
difference between Group A and Group B. Further we can observe that mean rank for Group A is greater than 
Group B. Hence we conclude that effect observed in Group A is more than Group B.  
Table 8: Assessment of overall effect of therapy on Karnsrava- otomycosis 
Overall Effect 
Group A Group B 
N % N % 
Complete Remission (100%) 2 6.67 0 0.00 
Marked Improvement (76-99%) 7 23.33 2 6.67 
Moderate Improvement (51-75%) 9 30.00 6 20.00 
Mild Improvement (26-50%) 12 40.00 22 73.33 
Unchanged (< 25%) 0 0.00 0 0.00 
TOTAL 30 100.00 30 100.00 
The overall effect of therapy was assessed on the basis of above mentioned assessment criteria.  
In group A, 40.00% patients got mild improvement, 30.00% patients got moderate improvement, 23.33% 
patients got marked improvement and 6.67% patients got complete remission. None of the patients remained 
unchanged. 
In Group B, 73.33% patients got mild improvement, 20.00% patients got moderate improvement and 6.67% 
patients got marked improvement and no patients got complete remission or remained unchanged. 
 
DISCUSSION  
Rasnadi Guggulu Vati 
According to our classics, Vata dosha is 
responsible for Karnsrava and Rasna has been 
referred to as one of the best Vata-hara Agreya 
Dravya in ch.su.25. (jkLuk okrgjk.kke). The Rasnadi 
guggulu vati is simple medicine having drugs like 
Rasna, Amrita, Eranda, Devadaru, Shunthi, Guggulu 
which are very cheap and easily available in their 
authentic form. The ingredients of Rasnadi guggulu 
vati have Shothahara, Kushthaghna, Vedanasthapana, 
Krimighna, Kaphaghna, Vranaropana, Jantughana, 
Vranashodhana, Rasayana, Vatahara etc., properties. 
Due to all these properties it can be effective in 
treating the disease Karnsrava- otomycosis. In 
modern science, some fungus species are resistant to 
antifungal eardrops and oral antifungal drugs such as 
itraconazole or voriconazole are not free from side 
effects like headache, vomiting, nausea etc. Hence, 
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Probable Mode of Action of Rasnadi Guggulu 
In Ayurveda, the probable mode of action of the drug is based upon the pharmacodynamics of the drug, 
which includes the Rasa, Guna, Virya, Vipaka and Doshaghnata.  
Table 9: Pharmacodynamic properties of various ingredients of Rasnadi guggulu vati
S. No. Ingredients Rasa Guna Virya Vipaka Doshaghnata 
1. Rasna Tikta Guru Ushna Katu Vata- kapha shamaka 
2. Amrita Tikta, 
Kashaya 
Guru, Snigdha Ushna Madhura Tridosha- shamaka 
3. Eranda Madhura Snigdha, Sukshma, 
Tikshna 
Ushna Madhura Kapha- vata shaman 
4. Devadaru Tikta Laghu, Snigdha Ushna Katu Kapha- vata shamaka 
5. Shunthi Katu Laghu, Snigdha Ushna Madhura Vata- kapha 
Shamaka 
6. Guggulu Katu-tikta Laghu, Ruksha, 
Tikshna 
Ushna Katu Vata – kapha shamaka 
Action by Doshaghnata  
All the drugs of Rasnadi guggulu vati are 
Vata- kapha shamaka, whereas Guggulu and Guduchi 
(Amrita) have Tridoshahara property. 
Action by Rasa 
Most of the drugs of Rasnadi guggulu vati are 
dominated by Tikta, Katu rasa. So, Rasnadi vati has 
Kapha shamaka property by Katu, tikta rasa and Vata 
and Pitta shamaka property by Madhura and Kashaya 
rasa. Acharya Charaka has described Katu rasa as 
Kandu hara, Krimihara, Agnideepana, Vrana 
ropana.[12] Tikta rasa acts as Krimihara, Kanduhara 
and Kashaya rasa acts as Ropana and Sandhanakara. 
Madhura rasa acts as Indriyaprasadhana, Ojo-
vardhaka, Dhatu vardhana and Daha prashama. Due 
to these properties Rasnadi guggulu vati helps in 
alleviating Karnsrava- otomycosis. 
Action by Guna 
Majority of the ingredients have Snigdha, 
Guru guna which helps in pacifying Vata dosha and 
some others drugs having Laghu and Tikshna guna 
which are Kaphashamaka.  
Action by Virya 
Virya is the efficiency of drug via which it 
really works i.e. quick or slow. Ushna virya drugs are 
those which work fast and efficiently in short period 
of time in comparison to sheeta virya. In Rasnadi 
guggulu vati almost all drugs have Ushna virya. So, it 
breaks the pathology more proficiently. 
Action by Vipaka 
Most of the drugs are having Katu and 
madhura vipaka. The Katu vipaka normalizes the 
vitiated Kapha and the Madhura vipaka pacifies the 
Vata dosha. 
 
Actions of Rasanadi Guggulu Vati on Karnsrava- 
Otomycosis 
Rasnadi guggulu has different ingredients which 
plays important role in the treatment of Karnsrava. 
 Rasnadi guggulu vati consists of six ingredients. It 
contains Rasna, Amrita, Eranda, Devadaru, Shunti 
in equal parts and five parts of Guggulu. 
 Guggulu is the chief ingredients in the composition 
of Rasnadi guggulu vati, its Katu – tikta rasa and 
Ushna virya reduces Vata and Meda. It is a 
demonstrated drug for its anti-inflammatory and 
anti-septic effect. Guggulu is lipid invigorating in 
action of white bloods cells in the body 
contributing to the building up of the immune 
system. 
 Rasayana drugs are considered as Samanya 
Chikitsa for all karnarogas in classics. So, it may be 
inferred that Guggulu has combined effect of anti-
inflammatory and immune-modulator thereby 
bringing relief in Karnsrava-otomycosis. 
 In Rasnadi Guggulu vati, most of the ingredients 
are having Tikta, Katu, Kashaya and Madhura rasa. 
They are having properties like Guru, Snigdha and 
Laghu guna, Ushna virya along with Katu and 
Madhura vipaka which are Vata- Kapha shamaka 
properties. By these properties it reduces Srava 
from the Karna leading to dryness of the ear canal. 
 The disease Karnsrava is mainly due to Vata dosha 
and Rasnadi guggulu vati contains drug like Rasna 
(vata pacifier), Eranda and Devadaru which are 
not only capable of pacifying Vata but also very 
good in promoting the health by normalizing the 
doshas. 
 Rasna is a known anti-inflammatory drug as well 
as disease modifying agent. Amrita, Devadaru, 
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Shunti have immune modulatory activity which 
aides in mitigating symptoms of Karnsrava-
otomycosis. 
 As indicated by Panchmahabhotika constitution, 
Karnsrava is Prithvi and Jala mahabhuta pradhan, 
while Rasnadi Guggulu has Akasha, Vayu and Teja 
mahabhoota pradhanata. The contradictory 
Mahabhuta pradhanata of the Karnastrava and 
Rasnadi Guggulu will be supportive to decrease 
the disease. 
 Rasna, Amrita (Guduchi), Guggulu work as a 
Rasayana because of it possesses the Rasayana 
property. Hence, Rasnadi guggulu vati helps in 
alleviating Karnsrava- otomycosis and its 
symptoms. Because it is said by Acharya Sushruta–  
lkekU;a d.kZjksxs"kq ?k`rikua jlk;ue~A 
 vO;k;keks·f'kj% Lukua czãp;ZedRFkue~AA 13 (Su.utt.21/3) 
Gugguluadi Karndhoopan Dravyas  
Selection of Treatment Modality 
Karndhoopan is one among natural and 
traditional procedure which can be beneficial in 
controlling the infections. Its root lies in Vedas and is 
broadly used in Ayurveda not only for disinfecting, 
but additionally as a remedy to prevent the various 
diseases. In Atharvaveda, it is mentioned in 
description that Yakshma and other diseases won’t 
spread to the areas fumigated by Guggulu.[14] After 
going via entire literature of Guggulu, it is introduced 
as a well known Dhoopan dravyas. The Gandha of 
Guggulu is mentioned as Krimighna and insect 
repellant. Guggulu is noted as a Devadhoopa in our 
classics. It tells about importance of Guggulu as a 
Dhoopan dravyas and Guggulu also has an aromatic 
fragrance. In this present study eight such drugs 
which are mentioned in Sushruta Samhita for 
Dhoopan (fumigation) namely Guggulu, Agaru, 
Sarjras, Vacha, Gaursarshapa, Lavana, Nimba and 
Ghrita has been selected for Karndhoopan karma. 
Karnsrava- otomycosis is a challenging disease due to 
its long term treatment and follow-up and 
Karndhoopan with Gugguluadi dravyas are highly 
efficient in curing the disease Karnsrava- otomycosis. 
All these Dhoopan drugs have qualities of 
Kushthahara, Krimihara, Kandughna and Vrana 
ropana. These properties of Gugguluadi dravya 
Karndhoopan not only helps in reducing the Srava but 
also prevent futher progression of the disease 
Karnsrava- otomycosis. 
Probable Mode of Action of Gugguluadi Dravyas Karndhoopan 
Pharmaco dynamic properties of various ingredients of Karndhoopan dravyas are as follows: 
S.No Ingredients Rasa Guna Virya Vipaka Doshaghnata 
1. Guggulu Katu- Tikta Laghu, Tikshna, 
Vishada, Ruksha. 
Ushna Katu Vata- kapha shamaka 
2. Agaru Katu- Tikta Laghu, Ruksha, Tikshna Ushna Katu Vata- kaphahara 
3. Sarjarasa Kashaya- Tikta Sheeta, Snigdha Ushna Katu Vata- pitta hara 
4. Vacha Katu- Tikta Laghu, Tikshna, Sara Ushna Katu Kapha- vata shamaka 





Laghu, Snigdha Sheeta Madhura Tridosha- hara 
7. Nimba patra Tikta- kashaya Laghu Sheeta Katu Kapha- pitta shamaka 
8. Go-Ghrita Madhura Guru, Snigdha, Mrdu Sheeta Madhura Vata- pitta 
prashamana 
Mode of Action by Doshaghnata 
Maximum drugs in Gugguluadi dravyas 
dhoopan varti are Vata- kapha shamaka, whereas 
Saindhav Lavana has Tridoshahara property and 
Nimba has Kapha- pitta shamaka and Go-Ghrita has 
Vata-Pitta Prashamana properties.  
Mode of Action as Per Rasa  
In Gugguluadi dravyas dhoopan varti, most of 
the drugs have katu and Tikta rasa followed by 
Kashaya and Madhura rasa. Katu rasa comprises of 
Vayu & Agni mahabhuta which also alleviates Kapha 
dosha. It also has Deepana, Pachana, Krimighna, 
Kusthaghna, Kandughan, Vrana ropana 
properties.[12&15] 
Tikta rasa is dominated with Vayu and Akasa 
mahabhuta. It possesses Deepana, Pachana, 
Kandughna and Kusthaghna properties. Tikta rasa 
induces dryness and cleanses with Krimighna and 
Puyashoshanakara properties. It will also help to 
eliminate ear discharge, debris and reduce itching. 
Due to these properties of Katu and Tikta rasa, 
Gugguluadi dravyas varti will encounter Vata – kapha 
dosha. 
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Kashaya rasa is made up of Prithvi- Vayu 
Mahabhuta which alleviates Pitta- kapha dosha. It has 
Ropana and Shoshana properties by which it lysis the 
fungus and bacteria. 
Madhura rasa has dominance of Prithvi and 
Jala mahabhuta which alleviates Vata and Pitta due 
to its Snigdha and Guru guna. It is also Saptadhatu 
Vardhaka, Oja Vardhaka, Indriyaprasadana, Tarpana, 
Brihmanaya and Sandhanakara. Thus, it is ultimately 
promoting healing process.  
Mode of Action as Per Guna 
In this drug, majority of the Gunas are Laghu, 
Ruksha, Tikshna and Vishada which have Shoshana 
and Shodhana property by which they will reduce the 
discharge in EAC and encounter the Kapha dosha. 
Laghu guna has ropana shakti which helps in healing 
wound. Due to Shighrakari property of Tikshna guna 
it starts activity very fast and will mitigate both Vata 
and Kapha dosha, Pitta dosha will be decreased due 
to its Sheeta and Mridu guna. Snigdha and Guru guna 
will mitigate Vata dosha. 
Mode of Action as Per Virya 
 Virya is the most potent Guna present in the 
drug. Majority of the drugs in Gugguluadi dravyas 
dhoopan varti have Ushna virya which has positive 
effect on vitiated Vata- kapha dosha. Sheeta virya will 
decrease the vitiated Pitta dosha. 
Mode of Action as Per Vipaka 
Majority of the ingredients in Gugguluadi 
dravyas karndhoopan varti have Katu vipaka which 
will work on pacifying the Kapha dosha. Some drugs 
have Madhura vipaka which will normalize the 
aggravated Vata dosha. 
In Gugguluadi dravyas karndhoopan varti, all 
the drugs have Kushtaghna, Kandughan, Krimighna, 
Vranaropana, Vrana shodhana properties which will 
reduce the symptoms of disease Karnsrava-
otomycosis. Thus, from the above description of 
Gugguluadi dravyas karndhoopan varti drugs, the 
overall effect appears to be Tridoshahara. 
Recommendations for Future Research Work 
 Karndhoopan with more different drugs can be 
chosen for the further study. 
 The study should be conducted with a longer 
duration of treatment. 
 The impact of Karndhoopan along with Nasya or 
Nasya alone can be attempted in Karnsrava-
otomycosis in further research work. 
 Advanced investigative procedures can be 
included for better prognosis and assessment. 
 The effectiveness of the therapeutic procedure 
Karndhoopan can be built up in C.S.O.M & A.S.O.M 
and other outer ear infections by further research 
studies. 
CONCLUSION  
Following conclusions can be drawn from the present 
study.  
 Most common etiology of Karnsrava is Jalakrida 
/Jalanimajjana, followed by Karnakanduyana in 
the present study. 
 In this study, the prevalence of Karnsrava-
otomycosis is seen additional in 21-30 years age 
group. 
 Vata- kapha prakriti persons are seen to be more 
prone for the disease Karnsrava- otomycosis. 
 It usually affects unilateral side i.e., 78.33% 
patients but bilateral side can also be affected. 
 In current study, Varsha Ritu (Aug-Sep) is 
favourable season for the diseases Karnsrava-
otomycosis.  
 Incidence of the disease Karnsrava was found to 
be more prevalent in the lower middle class i.e. 
48.33%. 
 In the disease Karnsrava ear discharge, ear pain & 
itching in EAC were the most significant 
complaints in almost cases. 
 Administration of Karndhoopan is safe, painless 
and harmless procedure which can be done at 
O.P.D. level without any complications. 
 Gugguluadi Dravyas Karndhoopan along with 
Rasnadi guggulu orally proved more effective 
when compared to only Karndhoopan with 
Gugguluadi dravyas.  
 All the drugs presents in Rasnadi Guggulu vati & 
Gugguluadi dravyas karndhoopan possesses 
kaphavata-hara & Tridoshahara properties which 
play an significant role in pacifying Doshas, 
participating in the pathogensis of the disease 
Karnsrava-otomycosis. 
 This clinical study proves that most of the drugs 
used in this research project possess anti-fungal, 
anti-bacterial, anti-inflammatory & 
immunomodulator properties. 
 None of the cases aggravated during the study. 
 No unfavourable effect of the therapy was 
observed during the study.  
Thus, finally we can conclude that Gugguluadi 
dravyas karndhoopan and Rasnadi Guggulu vati is 
safe, cost effective and free from any side effects in 
the management of Karnsrava. 
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